BioCentury | Mar 9, 2017
Finance

Pharmas learn their A, B, seeds

...for innovation. Last year, the fund participated in an $8.6 million series A round for ImmuneXcite Inc....
...Galecto Biotech AB, Copenhagen, Denmark GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. HepaRegenix GmbH, Ulm, Germany ImmuneXcite Inc....
BioCentury | Apr 4, 2016
Financial News

ImmuneXcite completes venture financing

ImmuneXcite Inc. , Watertown, Mass. Business: Cancer, Infectious, Antibodies Date completed: 2016-03-30 Type: Venture financing Raised: $8.6 million Investors: Cormorant Asset Management; Sanofi-Genzyme BioVentures; Partners Innovation Fund Note: The financing is a series A-1 round. WIR...
BioCentury | Jan 13, 2014
Financial News

ImmuneXcite completes venture financing

ImmuneXcite Inc. , Watertown, Mass. Business: Cancer, Infectious, Antibodies Date completed: 1/6/14 Type: Venture financing Raised: $3.6 million Investors: Private investors WIR Staff cancer Infectious...
BioCentury | Jan 16, 2012
Financial News

ImmuneXcite completes venture financing

ImmuneXcite Inc. , Watertown, Mass. Business: Cancer, Infectious, Antibodies Date completed: 1/3/12 Type: Venture financing Raised: $2.4 million Note: The company raised $2.4 million in a financing, according to an SEC filing. WIR Staff cancer Infectious...
BioCentury | Jan 14, 2012
Financial News

ImmuneXcite raises $2.4 million

ImmuneXcite Inc. (Watertown, Mass.) raised $2.4 million in a financing, according to an SEC filing. The company, which declined to comment, is developing technology to enhance the efficacy of mAbs for cancer and infectious disease...
Items per page:
1 - 5 of 5
BioCentury | Mar 9, 2017
Finance

Pharmas learn their A, B, seeds

...for innovation. Last year, the fund participated in an $8.6 million series A round for ImmuneXcite Inc....
...Galecto Biotech AB, Copenhagen, Denmark GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. HepaRegenix GmbH, Ulm, Germany ImmuneXcite Inc....
BioCentury | Apr 4, 2016
Financial News

ImmuneXcite completes venture financing

ImmuneXcite Inc. , Watertown, Mass. Business: Cancer, Infectious, Antibodies Date completed: 2016-03-30 Type: Venture financing Raised: $8.6 million Investors: Cormorant Asset Management; Sanofi-Genzyme BioVentures; Partners Innovation Fund Note: The financing is a series A-1 round. WIR...
BioCentury | Jan 13, 2014
Financial News

ImmuneXcite completes venture financing

ImmuneXcite Inc. , Watertown, Mass. Business: Cancer, Infectious, Antibodies Date completed: 1/6/14 Type: Venture financing Raised: $3.6 million Investors: Private investors WIR Staff cancer Infectious...
BioCentury | Jan 16, 2012
Financial News

ImmuneXcite completes venture financing

ImmuneXcite Inc. , Watertown, Mass. Business: Cancer, Infectious, Antibodies Date completed: 1/3/12 Type: Venture financing Raised: $2.4 million Note: The company raised $2.4 million in a financing, according to an SEC filing. WIR Staff cancer Infectious...
BioCentury | Jan 14, 2012
Financial News

ImmuneXcite raises $2.4 million

ImmuneXcite Inc. (Watertown, Mass.) raised $2.4 million in a financing, according to an SEC filing. The company, which declined to comment, is developing technology to enhance the efficacy of mAbs for cancer and infectious disease...
Items per page:
1 - 5 of 5